Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

A review of the current status of siRNA nanomedicines in the treatment of cancer.

Abstract :

RNA interference currently offers new opportunities for gene therapy by the specific extinction of targeted gene(s) in cancer diseases. However, the main challenge for nucleic acid delivery still remains its efficacy through intravenous administration. Over the last decade, many delivery systems have been developed and optimized to encapsulate siRNA and to specifically promote their delivery into tumor cells and improve their pharmacokinetics for anti-cancer purposes. This review aims to sum up the potential targets in numerous pathways and the properties of recently optimized siRNA synthetic nanomedicines with their preclinical applications and efficacy. Future perspectives in cancer treatment are discussed including promising concomitant treatment with chemotherapies or other siRNA. The outcomes in human clinical trials are also presented.

Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Okina Univ Angers Connectez-vous pour contacter le contributeur
Soumis le : mercredi 24 mars 2021 - 09:50:11
Dernière modification le : vendredi 24 juin 2022 - 04:01:59
Archivage à long terme le : : vendredi 25 juin 2021 - 18:21:16


Accord explicite pour ce dépôt



Pauline Resnier, Tristan Montier, Véronique Mathieu, Jean-Pierre Benoit, Catherine Passirani-Malleret. A review of the current status of siRNA nanomedicines in the treatment of cancer.. Biomaterials, Elsevier, 2013, 34 (27), pp.6429-43. ⟨10.1016/j.biomaterials.2013.04.060⟩. ⟨hal-03178911⟩



Consultations de la notice


Téléchargements de fichiers